REVERSAL OF CHRONIC VENTRICULAR DILATION IN PATIENTS WITH END-STAGE CARDIOMYOPATHY BY PROLONGED MECHANICAL UNLOADING

被引:334
作者
LEVIN, HR [1 ]
OZ, MC [1 ]
CHEN, JM [1 ]
PACKER, M [1 ]
ROSE, EA [1 ]
BURKHOFF, D [1 ]
机构
[1] COLUMBIA UNIV,COLL PHYS & SURG,DEPT SURG,DIV CARDIOTHORAC SURG,NEW YORK,NY 10032
关键词
DIASTOLE; HEART FAILURE; VENTRICLES; CARDIAC VOLUME;
D O I
10.1161/01.CIR.91.11.2717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Ventricular dilation, indexed by marked shifts toward larger volumes of the end-diastolic pressure-volume relation (EDPVR), has been considered to represent an irreversible aspect of ventricular remodeling in end-stage heart failure. However, we hypothesized that such dilation could be reversed with sufficient hemodynamic unloading, such as can be provided by a left ventricular assist device (LVAD). Methods and Results The EDPVRs of hearts from seven patients with end-stage idiopathic cardiomyopathy and comparable baseline hemodynamics were measured ex vivo at the time of cardiac transplantation; these were compared with EDPVRs from three normal human hearts that were technically unsuitable for transplantation Four of the patients received optimal medical therapy; three of the patients, who deteriorated on optimal therapy, underwent LVAD support for approximate to 4 months. Compared with the normal hearts, EDPVRs of hearts from medically treated patients were shifted toward markedly larger volumes. In contrast, EDPVRs of hearts from LVAD patients were similar to those of normal hearts. Conclusions Chronic hemodynamic unloading of sufficient magnitude and duration can result in reversal of chamber enlargement and normalization of cardiac structure as indexed by the EDPVR, both important aspects of remodeling, even in the most advanced stages of heart failure.
引用
收藏
页码:2717 / 2720
页数:4
相关论文
共 18 条
  • [1] BAUR LHB, 1991, BRIT HEART J, V65, P137
  • [2] BURKHOFF D, 1988, Heart and Vessels, V4, P185, DOI 10.1007/BF02058586
  • [3] FIRST USE OF AN UNTETHERED, VENTED ELECTRIC LEFT-VENTRICULAR ASSIST DEVICE FOR LONG-TERM SUPPORT
    FRAZIER, OH
    [J]. CIRCULATION, 1994, 89 (06) : 2908 - 2914
  • [4] MULTICENTER CLINICAL-EVALUATION OF THE HEARTMATE 1000-IP LEFT-VENTRICULAR ASSIST DEVICE
    FRAZIER, OH
    ROSE, EA
    MACMANUS, Q
    BURTON, NA
    LEFRAK, EA
    POIRIER, VL
    DASSE, KA
    [J]. ANNALS OF THORACIC SURGERY, 1992, 53 (06) : 1080 - 1090
  • [5] HALL S, 1994, CIRCULATION, V90, P543
  • [6] JACQUET L, 1991, J THORAC CARDIOV SUR, V101, P256
  • [7] INTRAVENOUS NITROGLYCERIN THERAPY TO LIMIT MYOCARDIAL INFARCT SIZE, EXPANSION, AND COMPLICATIONS - EFFECT OF TIMING, DOSAGE, AND INFARCT LOCATION
    JUGDUTT, BI
    WARNICA, JW
    [J]. CIRCULATION, 1988, 78 (04) : 906 - 919
  • [8] POTENTIAL OF LEFT-VENTRICULAR ASSIST DEVICES AS OUTPATIENT THERAPY WHILE AWAITING TRANSPLANTATION
    LEVIN, HR
    CHEN, JM
    OZ, MC
    CATANESE, KA
    KRUM, H
    GOLDSMITH, RL
    PACKER, M
    ROSE, EA
    [J]. ANNALS OF THORACIC SURGERY, 1994, 58 (05) : 1515 - 1520
  • [9] NEURO-HORMONAL INTERACTIONS AND ADAPTATIONS IN CONGESTIVE HEART-FAILURE
    PACKER, M
    [J]. CIRCULATION, 1988, 77 (04) : 721 - 730
  • [10] INFLUENCE OF CHRONIC CAPTOPRIL THERAPY ON THE INFARCTED LEFT-VENTRICLE OF THE RAT
    PFEFFER, JM
    PFEFFER, MA
    BRAUNWALD, E
    [J]. CIRCULATION RESEARCH, 1985, 57 (01) : 84 - 95